These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells. Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470 [TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines. Zhao H; Desai V; Wang J; Epstein DM; Miglarese M; Buck E Mol Cancer Ther; 2012 Feb; 11(2):503-13. PubMed ID: 22161861 [TBL] [Abstract][Full Text] [Related]
4. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506 [TBL] [Abstract][Full Text] [Related]
5. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation. Kiess W; Koepf G; Christiansen H; Blum WF Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729 [TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways. Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025 [TBL] [Abstract][Full Text] [Related]
7. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody. Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139 [TBL] [Abstract][Full Text] [Related]
9. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin. Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. Vanamala J; Reddivari L; Radhakrishnan S; Tarver C BMC Cancer; 2010 May; 10():238. PubMed ID: 20504360 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799 [TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt. Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells. Rowzee AM; Ludwig DL; Wood TL Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949 [TBL] [Abstract][Full Text] [Related]
14. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells. Wu YC; Zhu M; Robertson DM PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999 [TBL] [Abstract][Full Text] [Related]
15. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. Li M; Chiu JF; Gagne J; Fukagawa NK J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585 [TBL] [Abstract][Full Text] [Related]
16. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors. Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells. Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549 [TBL] [Abstract][Full Text] [Related]
18. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma. Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113 [TBL] [Abstract][Full Text] [Related]
19. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of angiogenesis by the IGF-1 receptor-targeting antibody SCH717454 is reversed by IGF-2. Bid HK; Zhan J; Phelps DA; Kurmasheva RT; Houghton PJ Mol Cancer Ther; 2012 Mar; 11(3):649-59. PubMed ID: 22188815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]